LAB7 Invests in Homeostasis to Advance CO2-to-Graphite Technology for Battery Production
LAB7 has partnered with U.S. startup Homeostasis to advance technology that transforms carbon dioxide into synthetic graphite for lithium-ion battery anodes, crucial for electric vehicles and energy storage. The collaboration, announced on December 30, utilizes molten-salt electrolysis to produce anode-grade graphite from captured CO2, enhancing Homeostasis' production processes. Supported by Aramco, this initiative aims to promote innovative industrial technologies while addressing climate challenges.
Theia Market Signal Identification - AI Assisted
LAB7 has entered a strategic investment with U.S. startup Homeostasis to develop technology that converts carbon dioxide (CO2) into synthetic graphite. Announced on December 30, the partnership aims to accelerate the transformation of CO2 emissions into high-value graphite for lithium-ion battery anodes, essential for electric vehicles and energy storage systems.
Homeostasis employs molten-salt electrolysis to produce anode-grade graphite from captured CO2 at industrial sites. This collaboration is part of LAB7's initiative to support startups in introducing innovative industrial technologies while addressing climate challenges.
The partnership will enhance Homeostasis' production processes and market readiness. Aramco's support for LAB7 strengthens the collaboration, aligning with efforts to produce sustainable critical battery materials.
Comments